Speakers:
Olga Klibanov, PharmD, BCPS
Professor of Pharmacy
Wingate University School of Pharmacy
Learning Objectives:
1. Describe the epidemiology, transmission, pathogenesis, and complications associated with chronic HCV.
2. Highlight patient populations that should be screened for chronic HCV
3. Review the common adverse events, DDIs, and contraindications with anti-HCV agents
4. Describe the genotypic activity of novel anti-HCV oral agents and their utility in the different HCV-infected patient types
5. Highlight the recommended treatment regimens for patients with HCV based on the most updated guidelines
Continuing Education:
Correspondence (1 hr)
Hepatitis C Virus (HCV) Update 2019 |
Distributors may purchase multiple copies of packages to distribute to learners, and follow their progress. Bulk discounts are below.
Quantity | Price per voucher |
---|---|
1+ | $0.00 |
North Carolina Association of Pharmacists
Privacy Policy